( 51 , 52 ) Furthermore, genetically engineered modified chimeric antigen receptor (CAR) -NK cells are being developed against AML and could be a potent strategy for targeting AML cells and inducing NK cell-mediated killing, including death through the secretion of FAS-L and TRAIL. The gene discussed is FASLG; the disease is acute myeloid leukemia.